Search Results - "Horvath N"

This result is not displayed to guests.
Login for full access.

Continuing Education: A Cooperative Endeavor.

Authors: Liveris, M. Horvath, N.

Source: Journal of Tertiary Educational Administration. May 1984 6(1):85-90.

Peer Reviewed: N

Page Count: 6

Descriptors: Allied Health Occupations Education, College Administration, Continuing Education, Coordination, Educational Needs, Foreign Countries, Higher Education, Needs Assessment, Professional Associations, Professional Continuing Education, Program Development, School Role

Geographic Terms: Australia

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation.

Authors: Spencer, A Horvath, N Gibson, J et al.

Source: Bone Marrow Transplantation. May2005, Vol. 35 Issue 10, p971-977. 7p.

Affective temperaments, anxiety, and depression as predictors of perioperative pain and analgesic requirements.

Authors: Mate-Horvath, N. Acs, N. Gonda, X.

Source: European Psychiatry. 2025 Supplement 1, Vol. 68, pS407-S408. 2p.

CD34⁺ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma.

Authors: Dyson, P G Horvath, N Joshua, D et al.

Source: Bone Marrow Transplantation. 6/1/2000, Vol. 25 Issue 11, p1175. 10p.

Inappropriate antidiuretic hormone secretion, abdominal pain and disseminated varicella-zoster virus infection: an unusual triad in a patient 6 months post mini-allogeneic peripheral stem cell transplant for chronic myeloid leukemia.

Authors: Szabó, F Horvath, N Seimon, S et al.

Source: Bone Marrow Transplantation. 7/15/2000, Vol. 26 Issue 2, p231. 3p.

Safety and efficacy results from an international Expanded Access Programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patients.

Authors: Quach, H. Horvath, N. Cannell, P. et al.

Source: Internal Medicine Journal. May2009, Vol. 39 Issue 5, p290-295. 6p. 1 Diagram, 2 Charts, 2 Graphs.

Outcome of patients with myelodysplastic syndromes - experience from a single institution in South Australia.

Authors: Hui C Horvath N Lewis I et al.

Source: Internal Medicine Journal. Nov2008, Vol. 38 Issue 11, p824-828. 5p.

URL: 35728943

Long-term follow up of sequential mobilisation and autologous transplantation with CD34-selected cells in multiple myeloma: a multimodality approach.

Authors: Horvath, N. Hahn, U. Joshua, D. et al.

Source: Internal Medicine Journal. Apr2004, Vol. 34 Issue 4, p167-175. 9p. 1 Diagram, 4 Charts, 5 Graphs.

This result is not displayed to guests.
Login for full access.

Response adaptive salvage with KTd and ASCT for functional high‐risk multiple myeloma—The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial.

Authors: Turner, R. Quach, H. Horvath, N. et al.

Source: British Journal of Haematology. Aug2023, Vol. 202 Issue 3, p530-538. 9p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Indices of accelerated erythropoiesis during a 6-day cycle race - abstract.

Authors: Martin, D.T. Boston, T. Parisotto, R. et al.

Source: 01/01/1999.

URL: http://www.ausport.gov.au/fulltext/1999/iocwc/abs014b.htm

Assessment of early paraprotein response to vincristine-doxorubicin-dexamethasone chemotherapy may help guide therapy in multiple myeloma.

Authors: Ross, D. M. To, L. B. Horvath, N.

Source: Internal Medicine Journal. Sep/Oct2004, Vol. 34 Issue 9/10, p576-577. 3p. 1 Chart, 1 Graph.

Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHD.

Authors: Roberts, M. M. Dyson, P. Rawling, C. et al.

Source: Cytotherapy (Taylor & Francis Ltd). Nov2003, Vol. 5 Issue 6, p534-541. 8p. 2 Charts, 1 Graph.

Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a report of two cases.

Authors: Hui, C.H. Bardy, P. Hughes, T. et al.

Source: Clinical & Laboratory Haematology. Apr2001, Vol. 23 Issue 2, p135-138. 4p.

Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSF.

Authors: Lie, A K W Hui, C H Rawling, T et al.

Source: Bone Marrow Transplantation. 11/1/98, Vol. 22 Issue 9, p853. 5p.

Cardiac Amyloidosis Secondary to Light-Chain Deposition: The Effect of Daratumumab on Clinical Heart Failure Progression in an Elderly Male.

Authors: Barbaro, D. Clarke, N. Gunawardane, D. et al.

Source: Heart, Lung & Circulation. 2024 Supplement 4, Vol. 33, pS249-S249. 1p.

Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

Authors: Weber, N. Mollee, P. Augustson, B. et al.

Source: Internal Medicine Journal. Apr2015, Vol. 45 Issue 4, p371-382. 11p.